Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Vikse

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 5, 2024
Jens Vikse
Clinical Therapeutics|February 25, 2019
Fatigue in Mastocytosis: A Case SeriesJens Vikse, Roald Omdal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 7, 2017
[Hypoxia or hypoxemia?]Jens Vikse, Børge Førland Gjøse
The New England Journal of Medicine|March 29, 2020
Clinical Characteristics of Covid-19 in ChinaBrandon M Henry, Jens Vikse
International Journal of Antimicrobial Agents|May 12, 2020
Tocilizumab in COVID-19: Beware the risk of intestinal perforationJens Vikse, Brandon Michael Henry
The Lancet. Infectious Diseases|November 28, 2017
A travelling camper with a spiking fever, headache, myalgia, hepatitis, and intracellular inclusionsJens Vikse, Jan Klos, Aase Berg
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 6, 2017
[IgG4-related disease]Jens Vikse, Sven Håland, Katrine Brække Norheim
Diagnosis (Berlin, Germany)|June 19, 2020
Do sex-specific immunobiological factors and differences in angiotensin converting enzyme 2 (ACE2) expression explain increased severity and mortality of COVID-19 in males?Jens Vikse, Giuseppe Lippi, Brandon Michael Henry
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 29, 2019
Purple urine bag syndromeJens Vikse, Marte Zakariassen Sæverås, Eva Marianne Staal, et al.
Rheumatology International|March 30, 2019
Tolerability and safety of long-term rituximab treatment in systemic inflammatory and autoimmune diseasesJens Vikse, Kristin Jonsdottir, Jan Terje Kvaløy, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 5, 2024
Jens Vikse
Clinical Therapeutics|February 25, 2019
Fatigue in Mastocytosis: A Case SeriesJens Vikse, Roald Omdal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 7, 2017
[Hypoxia or hypoxemia?]Jens Vikse, Børge Førland Gjøse
The New England Journal of Medicine|March 29, 2020
Clinical Characteristics of Covid-19 in ChinaBrandon M Henry, Jens Vikse
International Journal of Antimicrobial Agents|May 12, 2020
Tocilizumab in COVID-19: Beware the risk of intestinal perforationJens Vikse, Brandon Michael Henry
The Lancet. Infectious Diseases|November 28, 2017
A travelling camper with a spiking fever, headache, myalgia, hepatitis, and intracellular inclusionsJens Vikse, Jan Klos, Aase Berg
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 6, 2017
[IgG4-related disease]Jens Vikse, Sven Håland, Katrine Brække Norheim
Diagnosis (Berlin, Germany)|June 19, 2020
Do sex-specific immunobiological factors and differences in angiotensin converting enzyme 2 (ACE2) expression explain increased severity and mortality of COVID-19 in males?Jens Vikse, Giuseppe Lippi, Brandon Michael Henry
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 29, 2019
Purple urine bag syndromeJens Vikse, Marte Zakariassen Sæverås, Eva Marianne Staal, et al.
Rheumatology International|March 30, 2019
Tolerability and safety of long-term rituximab treatment in systemic inflammatory and autoimmune diseasesJens Vikse, Kristin Jonsdottir, Jan Terje Kvaløy, et al.
Pageof 7